Vivos Therapeutics (VVOS) Debt Ratio (2019 - 2026)
Vivos Therapeutics' (VVOS) quarterly Debt Ratio came in at 0.34 in Q2 2026, up 10.83% year-over-year from 0.3 in Q2 2025, and up 9.38% quarter-over-quarter from 0.31 in Q1 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Debt Ratio (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Debt Ratio for 5 consecutive years, with 0.34 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Debt Ratio rose 10.83% year-over-year to 0.34 in Q2 2026; TTM through Jun 2026 was 0.34, a 10.83% increase from a year earlier, with the FY2025 full-year figure at 0.35, changed N/A from the prior year.
- Debt Ratio was 0.34 for Q2 2026 at Vivos Therapeutics, up from 0.31 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.35 in Q4 2025 and troughed at 0.3 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | - |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 0.26 |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 0.43 |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | - |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 7.84 |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 0.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.34 |
| Mar 31, 2026 | 0.31 |
| Dec 31, 2025 | 0.35 |
| Sep 30, 2025 | 0.34 |
| Jun 30, 2025 | 0.30 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.06 |
| Dec 31, 2020 | 0.08 |
| Dec 31, 2019 | 0.49 |